Cipla net up by 9.5 per cent to Rs 768 crore during FY'09

Mumbai-Cipla, the third largest pharmaceutical company in India, has achieved satisfactory performance during the year ended March 2009 despite slow down in world economy and significant jump in interest cost. The company's net profit increased by 9.5 per cent to Rs 767.83 crore from Rs 701.43 crore in the previous year. Its net sales moved up strongly by 24.4 per cent to Rs 4972.69 crore from Rs 3997.90 crore. The company's total exports has taken quantum jump and increased by 31.1 per cent to Rs 2754.41 crore from Rs 2101.74 crore in the 2007-08. Exports contribute 54.7 per cent to its sales as against 51.4 per cent in the previous year. Its exports of formulations increased by 39.8 per cent to Rs 2172.48 crore from Rs 1553.68 crore and that of APIs and others increased by 6.2 per cent to Rs 581.93 crore from Rs 548.06 crore. Its domestic sales increased by 14.7 per cent to Rs 2279 crore from Rs 1987 crore. The operating profit went up by 49.1 per cent to Rs 1284 crore from Rs 861 crore with a operating profit margins of 24.1 per cent as compared to 20 per cent in the last year. The foreign exchange loss amounted to Rs 10 crore as against a gain of Rs 25 crore in the previous year.